BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 6233362)

  • 1. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC; Hilfiker ML; Battisto JR
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with minor histocompatibility antigens prevents the development of functional CTL helper cell activity.
    Hayes RL; Claman HN
    J Immunol; 1983 Jan; 130(1):56-62. PubMed ID: 6216288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function.
    Gautam SC; Battisto JR
    Reg Immunol; 1989; 2(1):33-41. PubMed ID: 2534947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction in vivo between hapten-specific suppressor T cells and an in vitro cultured helper T cell line.
    Owens T; Miller JF
    J Immunol; 1987 Mar; 138(6):1687-92. PubMed ID: 2950167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo generation of hapten-specific killer T cells without elimination of suppressor cells.
    Butler LD; Battisto JR
    J Immunol; 1979 Apr; 122(4):1578-81. PubMed ID: 312846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell response.
    Scott CF; Tsurufuji M; Benacerraf B; Sy MS
    J Immunol; 1983 Nov; 131(5):2184-9. PubMed ID: 6195256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
    Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
    J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
    Wong HL; Battisto JR
    Eur J Immunol; 1984 Jul; 14(7):629-33. PubMed ID: 6235115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.
    Fujiwara H; Shearer GM
    Eur J Immunol; 1981 Sep; 11(9):700-4. PubMed ID: 6975212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of alloreactive cytotoxic responses in vivo are inhibited by pretreatment with M is-disparate cells.
    Hayes RL; Claman HN
    J Immunol; 1982 Jul; 129(1):232-5. PubMed ID: 6806359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.